Cited by 134Cholesterol and Lipid MetabolismCancer, Lipids, and MetabolismLipid metabolism and biosynthesis

Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice

Open access
Rong, Shunxing, Cortés, Víctor A, Rashid, Shirya, Anderson, Norma N, McDonald, Jeffrey G, Liang, Guosheng, Moon, Young-Ah, Hammer, Robert E +1 more·2017·eLife

Abstract

The synthesis of cholesterol and fatty acids (FA) in the liver is independently regulated by SREBP-2 and SREBP-1c, respectively. Here, we genetically deleted Srebf-2 from hepatocytes and confirmed that SREBP-2 regulates all genes involved in cholesterol biosynthesis, the LDL receptor, and PCSK9; a secreted protein that degrades LDL receptors in the liver. Surprisingly, we found that elimination of Srebf-2 in hepatocytes of mice also markedly reduced SREBP-1c and the expression of all genes involved in FA and triglyceride synthesis that are normally regulated by SREBP-1c. The nuclear receptor LXR is necessary for Srebf-1c transcription. The deletion of Srebf-2 and subsequent lower sterol synthesis in hepatocytes eliminated the production of an endogenous sterol ligand required for LXR activity and SREBP-1c expression. These studies demonstrate that cholesterol and FA synthesis in hepatocytes are coupled and that flux through the cholesterol biosynthetic pathway is required for the maximal SREBP-1c expression and high rates of FA synthesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.25015

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Genes in the cholesterol-biosynthesis pathway, including TFs such as SREBP that regulate lipid synthesis, are all upregulated in LOAD-risk-allele iMGs.

    “The de novo cholesterol and fatty acid synthesis in LOAD-risk-allele iMGs may contribute to LD accumulation: genes in the cholesterol-biosynthesis pathway, including TFs (such as SREBP) that regulate lipids synthesis35, were all upregulated (Fig. 4b and Supplementary Fig. 8).”
  • De novo cholesterol and fatty acid synthesis in LOAD-risk-allele iMGs may contribute to LD accumulation.

    “The de novo cholesterol and fatty acid synthesis in LOAD-risk-allele iMGs may contribute to LD accumulation: genes in the cholesterol-biosynthesis pathway, including TFs (such as SREBP) that regulate lipids synthesis35, were all upregulated (Fig. 4b and Supplementary Fig. 8).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 34 · Cited by 134

Research works printed but not linked: 30

  1. Brown MS Goldstein JL 2009 Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL Journal of Lipid Research 50 Suppl S15 27 10.1194/jlr.R800054-JLR200 18974038 PMC2674699 · DOI
  2. Engelking LJ Kuriyama H Hammer RE Horton JD Brown MS Goldstein JL Liang G 2004 Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis Journal of Clinical Investigation 113 1168 1175 10.1172/JCI20978 15085196 PMC385408 · DOI
  3. Horton JD Bashmakov Y Shimomura I Shimano H 1998 Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice PNAS 95 5987 5992 10.1073/pnas.95.11.5987 9600904 PMC27572 · DOI
  4. Horton JD Shimano H Hamilton RL Brown MS Goldstein JL 1999 Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL Journal of Clinical Investigation 103 1067 1076 10.1172/JCI6246 10194480 PMC408267 · DOI
  5. Horton JD Shah NA Warrington JA Anderson NN Park SW Brown MS Goldstein JL 2003 Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes PNAS 100 12027 12032 10.1073/pnas.1534923100 14512514 PMC218707 · DOI
  6. Huang C 2014 Natural modulators of liver X receptors Journal of Integrative Medicine 12 76 85 10.1016/S2095-4964(14)60013-3 24666673 · DOI
  7. Im SS Hammond LE Yousef L Nugas-Selby C Shin DJ Seo YK Fong LG Young SG Osborne TF 2009 Sterol regulatory element binding protein 1a regulates hepatic fatty acid partitioning by activating acetyl coenzyme A carboxylase 2 Molecular and Cellular Biology 29 4864 4872 10.1128/MCB.00553-09 19564420 PMC2725716 · DOI
  8. Ishibashi S Brown MS Goldstein JL Gerard RD Hammer RE Herz J 1993 Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery Journal of Clinical Investigation 92 883 893 10.1172/JCI116663 8349823 PMC294927 · DOI
  9. Ishii S Iizuka K Miller BC Uyeda K 2004 Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription PNAS 101 15597 15602 10.1073/pnas.0405238101 15496471 PMC524841 · DOI
  10. Lagace TA Curtis DE Garuti R McNutt MC Park SW Prather HB Anderson NN Ho YK Hammer RE Horton JD 2006 Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice Journal of Clinical Investigation 116 2995 3005 10.1172/JCI29383 17080197 PMC1626117 · DOI · Paper page
  11. Li JZ Huang Y Karaman R Ivanova PT Brown HA Roddy T Castro-Perez J Cohen JC Hobbs HH 2012 Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis Journal of Clinical Investigation 122 4130 4144 10.1172/JCI65179 23023705 PMC3484461 · DOI
  12. Liang G Yang J Horton JD Hammer RE Goldstein JL Brown MS 2002 Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c Journal of Biological Chemistry 277 9520 9528 10.1074/jbc.M111421200 11782483 · DOI · Paper page
  13. Matsuda M Korn BS Hammer RE Moon YA Komuro R Horton JD Goldstein JL Brown MS Shimomura I 2001 SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation Genes & Development 15 1206 1216 10.1101/gad.891301 11358865 PMC313801 · DOI
  14. McDonald JG Thompson BM McCrum EC Russell DW 2007 Extraction and analysis of sterols in biological matrices by high performance liquid chromatography electrospray ionization mass spectrometry Methods in Enzymology 432 145 170 10.1016/S0076-6879(07)32006-5 17954216 · DOI
  15. McFarlane MR Cantoria MJ Linden AG January BA Liang G Engelking LJ 2015 Scap is required for sterol synthesis and crypt growth in intestinal mucosa Journal of Lipid Research 56 1560 1571 10.1194/jlr.M059709 25896350 PMC4513997 · DOI
  16. Moon YA Liang G Xie X Frank-Kamenetsky M Fitzgerald K Koteliansky V Brown MS Goldstein JL Horton JD 2012 The scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals Cell Metabolism 15 240 246 10.1016/j.cmet.2011.12.017 22326225 PMC3662050 · DOI · Paper page
  17. Owen JL Zhang Y Bae SH Farooqi MS Liang G Hammer RE Goldstein JL Brown MS 2012 Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase PNAS 109 16184 16189 10.1073/pnas.1213343109 22927400 PMC3479583 · DOI
  18. Park SW Moon YA Horton JD 2004 Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver Journal of Biological Chemistry 279 50630 50638 10.1074/jbc.M410077200 15385538 · DOI
  19. Rashid S Curtis DE Garuti R Anderson NN Bashmakov Y Ho YK Hammer RE Moon YA Horton JD 2005 Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9 PNAS 102 5374 5379 10.1073/pnas.0501652102 15805190 PMC556275 · DOI · Paper page
  20. Repa JJ Liang G Ou J Bashmakov Y Lobaccaro JM Shimomura I Shan B Brown MS Goldstein JL Mangelsdorf DJ 2000 Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta Genes & Development 14 2819 2830 10.1101/gad.844900 11090130 PMC317055 · DOI
  21. Romeo S Kozlitina J Xing C Pertsemlidis A Cox D Pennacchio LA Boerwinkle E Cohen JC Hobbs HH 2008 Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nature Genetics 40 1461 1465 10.1038/ng.257 18820647 PMC2597056 · DOI · Paper page
  22. Shimano H Horton JD Hammer RE Shimomura I Brown MS Goldstein JL 1996 Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a Journal of Clinical Investigation 98 1575 1584 10.1172/JCI118951 8833906 PMC507590 · DOI
  23. Shimano H Shimomura I Hammer RE Herz J Goldstein JL Brown MS Horton JD 1997 Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene Journal of Clinical Investigation 100 2115 2124 10.1172/JCI119746 9329978 PMC508404 · DOI
  24. Shimomura I Shimano H Horton JD Goldstein JL Brown MS 1997 Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells Journal of Clinical Investigation 99 838 845 10.1172/JCI119247 9062340 PMC507890 · DOI
  25. Shimomura I Bashmakov Y Ikemoto S Horton JD Brown MS Goldstein JL 1999 Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes PNAS 96 13656 13661 10.1073/pnas.96.24.13656 10570128 PMC24120 · DOI
  26. Smagris E BasuRay S Li J Huang Y Lai KM Gromada J Cohen JC Hobbs HH 2015 Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis Hepatology 61 108 118 10.1002/hep.27242 24917523 PMC4262735 · DOI · Paper page
  27. Vergnes L Chin RG de Aguiar Vallim T Fong LG Osborne TF Young SG Reue K 2016 SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression Journal of Lipid Research 57 410 421 10.1194/jlr.M064022 26685326 PMC4766990 · DOI
  28. Yang H Cromley D Wang H Billheimer JT Sturley SL 1997 Functional expression of a cDNA to human acyl-coenzyme A:cholesterol acyltransferase in yeast. Species-dependent substrate specificity and inhibitor sensitivity Journal of Biological Chemistry 272 3980 3985 10.1074/jbc.272.7.3980 9020103 · DOI
  29. Yang J Goldstein JL Hammer RE Moon YA Brown MS Horton JD 2001 Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene PNAS 98 13607 13612 10.1073/pnas.201524598 11717426 PMC61088 · DOI
  30. Yang C McDonald JG Patel A Zhang Y Umetani M Xu F Westover EJ Covey DF Mangelsdorf DJ Cohen JC Hobbs HH 2006 Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands Journal of Biological Chemistry 281 27816 27826 10.1074/jbc.M603781200 16857673 · DOI

Authors
Rong, S., Cortés, V. A., Rashid, S., Anderson, N. N., McDonald, J. G., Liang, G., Moon, Y.-A., Hammer, R. E., & Horton, J. D.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, United States
Corresponding author
Horton, Jay D
Venue
eLife
Published
2017-02-28
Volume
6
ISSN
2050-084X (ISSN-L)
OpenAlex
W2592226915
Cited by
134
References
34
Citations by year
2026: 16 · 2025: 18 · 2024: 17 · 2023: 10 · 2022: 13 · 2021: 11 · 2020: 17 · 2019: 10 · 2018: 9 · 2017: 13
FWCI
13.73
Type
journal article
Language
en
Open access
Locations
  • eLife (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institutes of Health (HL-20948)
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
SREBP-1c, SREBP2, liver X receptor, cholesterol biosynthesis, fatty acid synthesis, triglyceride synthesis, hepatocytes, LDL receptor, PCSK9, transcriptional regulation, hepatic lipid metabolism
MeSH terms
Liver X Receptors, Animals, Cholesterol, Fatty Acids, Gene Expression Regulation, Liver, Transcription, Genetic, Mice, Knockout, Mice, Sterol Regulatory Element Binding Protein 1, Sterol Regulatory Element Binding Protein 2, Gene Knockout Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review